Efficacy of outpatient treatment of alcohol use disorder
Not Applicable
- Conditions
- Alcohol use disorder.A cluster of behavioural, cognitive, and physiological phenomena that develop after repeated substance use and that typically include a strong desire to take the drug, difficulties in controlling its use, persisting in its use despite harmful consequences
- Registration Number
- IRCT20170702034844N3
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
Age: 18 to 65 years old
Diagnosis of alcohol use disorder based on DSM-5
Providing informed written consent
Exclusion Criteria
Severe co-morbid psychiatric disorder including psychosis or suicide
Inappropriate for outpatient treatment due to lack of family support, history of delirium tremens (DT) or seizures during previous alcohol withdrawal attempts
Inappropriate for outpatient treatment due to severe alcohol dependence defined by score over 30 in SADQ test
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment retention. Timepoint: Weekly for 12 weeks. Method of measurement: Participation in weekly individual psychotherapy session.
- Secondary Outcome Measures
Name Time Method Alcohol use disorders screening. Timepoint: Baseline and weeks 4 and 12. Method of measurement: Alcohol Use Disorder Identification Test (AUDIT).;Severity of alcohol dependence. Timepoint: Baseline and weeks 4 and 12. Method of measurement: Severity of Alcohol Dependence Questionnaire (SADQ).;Alcohol addiction severity. Timepoint: Baseline and week 12. Method of measurement: Alcohol section of Addiction Severity Index (ASI).;Aspartate Aminotransferase (AST). Timepoint: Baseline and weeks 4 and 12. Method of measurement: Blood test.;Alanine Aminotransferase (ALT). Timepoint: Baseline and weeks 4 and 12. Method of measurement: Blood test.;Gamma-Glutamyl Transferase (GGT). Timepoint: Baseline and weeks 4 and 12. Method of measurement: Blood test.